Michigan SIGHT 2 Study for Eye Health

This study, called Michigan SIGHT 2, is looking at different ways to detect serious eye diseases like glaucoma, diabetic retinopathy, and cataracts, which are major causes of blindness. Researchers want to compare a new "technology enhanced eye disease detection protocol" with a standard eye exam (called "standard optometric examination") at a community health center. They will see which method is better at finding these conditions. You might be able to join if you are 18 or older and speak one of several languages, including English and Spanish. The study is looking for about 900 participants. The main goal is to see the rate of vision-threatening eye diseases found at your first visit.

Study design
This interventional study plans to enroll 900 participants. It compares two different methods for detecting eye diseases.
What's involved
Participants will receive either a standard optometric examination or a technology enhanced eye disease detection protocol, which includes various eye measurements and imaging.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints, which measure the rate of vision-threatening eye disease, are assessed at Visit 1 (Day 1).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06934577

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

Recruiting
NAAges 18+InterventionalHealth services
University of Michigan
~900 participants
Updated 2025-12-15 on ClinicalTrials.gov
What's tested:Standard optometric examinationTechnology enhanced eye disease detection protocol

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of vision threatening eye disease (glaucoma/suspected glaucoma, visually significant cataract, diabetic retinopathy)
Measured over Visit 1(day 1)
+3 more outcomes measured
Eye Diseases
Visual Impairment
Glaucoma
1 sites across 1 states
Michigan1
  • Paula Anne Newman-Casey, MD · PRINCIPAL_INVESTIGATOR · University of Michigan

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

significant eye pain
sudden decrease in vision within one week
binocular diplopia
cognitive impairment
pregnancy
previously declined participation
  • Rate of vision threatening eye disease (glaucoma/suspected glaucoma, visually significant cataract, diabetic retinopathy)Visit 1(day 1)
  • Rate of glaucoma/suspected glaucomaVisit 1 (Day 1)
  • Rate of visually significant cataractVisit 1(day 1)

    Visually significant cataract is defined as presence of cataract with best corrected visual acuity ≤ 20/40 in the absence of other pathology.

  • Rate of diabetic retinopathyVisit 1(day 1)